最新ニュース Marchex (NASDAQ:MCHX) 株価情報

Marchex

Marchex Inc harnesses the power of AI and conversational intelligence to provide actionable insights aligned with prescriptive vertical market data analytics, driving operational excellence and revenue acceleration. Marchex enables executive, sales, and marketing teams to optimize customer journey experiences across communications channels, enabling enterprise strategy, empowering businesses to increase revenue through informed decision-making and strategic execution.

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

LUMN

MCHX

仮想通貨（仮想通貨）の総ロック価値（TVL）は、2024年8月7日時点で約3.8兆ドル（約X円）に達しました。投資家にとっては、株価の勢いを重要視するポイントがあるため、通信サービス部門の2つの銘柄が警告を発しているかもしれません。

仮想通貨市場の動向　企業への影響も視野に

Marchex Inc

Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $12.553 million which missed the analyst consensus estimate of $12.593 million by 0.32 percent. This is a 1.76 percent decrease over sales of $12.778 million the same period last year.

Earnings

Earnings Misses

Marchex Q3 2024 Adj. EPS $(0.01), Inline, Sales $12.553M Miss $12.593M Estimate

Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) sees Q4 sales of $12.000 million vs $12.59 million estimate.

Guidance

Marchex Sees Q4 Sales $12.000M vs $12.59M Est

Marchex Sees Q3 Revenue $12.6M+

Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. The company reported quarterly sales of $12.074 million which missed the analyst consensus estimate of $12.136 million by 0.51 percent. This is a 3.58 percent decrease over sales of $12.522 million the same period last year.

Marchex Q2 2024 Adj. EPS $(0.01), Inline, Sales $12.074M Miss $12.136M Estimate

As of Aug 7, 2024, two stocks in the communication services sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Marchex Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>)</h3>
<ul>
<li>Marchex will release financial results for its second quarter of 2024, on Aug. 8, 2024.  The company's stock gained around 31% over the past month and has a <a href="https://www.benzinga.com/quote/MCHX">52-week high of $1.99</a>.</li>
<li>RSI Value: 73.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>MCHX Price Action: Shares of Marchex gained 2.8% to close at $1.86 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Lumen Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>)</h3>
<ul>
<li>On Aug. 6, Lumen Technologies reported quarterly losses of 13 cents per share, which missed the analyst consensus estimate of losses of 6 cents per share. Quarterly sales came in at $3.268 billion, which beat the analyst consensus estimate of $3.246 billion by 0.69%. "The rising demand of AI is requiring greater connectivity between data centers, and Lumen's world-class fiber network and forward-thinking digital services are positioning us to help drive the AI growth wave," said Kate Johnson, president and CEO of Lumen Technologies. "We feel confident in our future growth and business transformation as we look to enable the AI economy." The company's stock gained around 372% over the past month and <a href="https://www.benzinga.com/quote/LUMN">has a 52-week high</a> of $5.30.</li>
<li>RSI Value: 89.54</li>
<li>LUMN Price Action: Shares of Lumen Technologies jumped 93.1% to close at $5.00 on Tuesday.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40194186/top-4-materials-stocks-which-could-rescue-your-portfolio-this-month">Top 4 Materials Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>

Top 2 Tech And Telecom Stocks That May Crash In August

ADBE

ASML

BABA

BBAI

BFRG

BIDU

CRWD

CXAI

GFAI

GOOG

GOOGL

INTC

INTU

LPSN

MARK

MSFT

NNDM

NVDA

ORCL

PLTR

QCOM

SMCI

SNAP

SNOW

SOUN

SSTK

TBLA

TSLA

VERI

ZPTA

Multiple AI Companies Are Bypassing Tool Used By Publishers To Stop Content Scraping, Licensing Startup Tollbit Says

The Dow Jones index closed higher by 0.25% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">PodcastOne</h3>
<ul>
<li>The Trade: PodcastOne, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODC#NASDAQ">PODC</a>) Director D Jonathan Merriman <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 48,839 shares</a> at an average price of $1.93. To acquire these shares, it cost around $93,641.</li>
<li>What's Happening: On May 30, PodcastOne raised its FY25 revenue guidance.</li>
<li>What PodcastOne Does: PodcastOne Inc formerly CourtSide Group Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.</li>
</ul>
<h3 class="wp-block-heading">BARK</h3>
<ul>
<li>The Trade: BARK, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BARK#NYSE">BARK</a>) Executive Chairman Matt Meeker <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 38,461 shares</a> at an average price of $1.39. To acquire these shares, it cost around $53,530.</li>
<li>What's Happening: On June 3, BARK reported worse-than-expected fourth-quarter financial results and issued FY25 revenue guidance below estimates.</li>
<li>What BARK Does: BARK Inc is a dog-centric company, devoted to making dogs happy with the products, services, and content.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/24/06/39182518/top-4-consumer-stocks-that-may-implode-in-q2">Top 4 Consumer Stocks That May Implode In Q2</a>
<h3 class="wp-block-heading">Fathom Holdings</h3>
<ul>
<li>The Trade: Fathom Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTHM#NASDAQ">FTHM</a>) Director Scott N Flanders <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 12,648 shares</a> at an average price of $1.74. The insider spent around $22,049 to buy those shares. </li>
<li>What's Happening: On May 28, Fathom Holdings named Jon Gwin as its new COO.</li>
<li>What Fathom Holdings Does: Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent.</li>
</ul>
<h3 class="wp-block-heading">Sypris Solutions</h3>
<ul>
<li>The Trade: Sypris Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYPR#NASDAQ">SYPR</a>) Director Gary L Convis <a href="https://www.benzinga.com/quote/SYPR/analyst-ratings">acquired a total of 1,274 shares</a> at an average price of $1.58. The insider spent around $2,013 to buy those shares.</li>
<li>What's Happening: On June 3, Sypris named Michael D. Sedgwick as Vice President and General Manager of Sypris Electronics, LLC.</li>
<li>What Sypris Solutions Does: Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics.</li>
</ul>
<h3 class="wp-block-heading">Marchex</h3>
<ul>
<li>The Trade: Marchex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) CEO Edwin A Miller <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 200,000 shares</a> at an average price of $1.36. The insider spent $272,000 to buy those shares.</li>
<li>What's Happening: On May 7, Marchex posted downbeat quarterly sales.</li>
<li>What Marchex Does: Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business.</li>
</ul>
Don&#8217;t forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>

Long Ideas

Penny Stocks

Insider Trades

BARK

FTHM

PODC

SYPR

Marchex And 4 Other Stocks Under $2 Insiders Are Buying

The Dow Jones index closed lower by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVP#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 1,210 shares</a> at an average price of $1.12. To acquire these shares, it cost around $1,355.</li>
<li>What's Happening: On May 15, Retractable Technologies posted a decline in quarterly sales.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
<h3 class="wp-block-heading">Marchex</h3>
<ul>
<li>The Trade: Marchex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) CEO Edwin A Miller <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 7,723 shares at</a> an average price of $1.40. To acquire these shares, it cost around $10,803.</li>
<li>What's Happening: On May 7, Marchex posted downbeat quarterly sales.</li>
<li>What Marchex Does: Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business.</li>
</ul>
<h3 class="wp-block-heading">Reneo Pharmaceuticals</h3>
<ul>
<li>The Trade: Reneo Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPHM#NASDAQ">RPHM</a>) 10% owner Braden Michael Leonard <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 414,281 shares</a> at an average price of $1.54. The insider spent around $639,578 to buy those shares.</li>
<li>What's Happening: On May 13, Reneo Pharmaceuticals entered into a merger agreement with OnKure.</li>
<li>What Reneo Pharmaceuticals Does: Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/05/38872018/top-5-utilities-stocks-you-may-want-to-dump-in-may">Top 5 Utilities Stocks You May Want To Dump In May</a>

RPHM

Reneo Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying

Marchex Sees Q2 2024 Revenue ~$12M Or More Vs $12.53M Estimate

WIIM

Marchex shares are trading higher. The company reported Q1 financial results.

Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 75 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $11.57 million which missed the analyst consensus estimate of $11.95 million by 3.15 percent. This is a 5.14 percent decrease over sales of $12.20 million the same period last year.

Marchex Q1 Adj $(0.02), Inline, Sales $11.57M Miss $11.95M Estimate

<h3>Gainers</h3>
<ul>
<li>Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) stock rose 16.9% to $57.73 during Tuesday's after-market session. The company's market cap stands at $9.3 billion. As per the press release, Q1 earnings came out today. </li>
<li>Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) stock moved upwards by 11.19% to $1.49. The company's market cap stands at $65.0 million. As per the press release, Q1 earnings came out today. </li>
<li>Nextdoor Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KIND#NYSE">KIND</a>) stock rose 9.69% to $2.49. The market value of their outstanding shares is at $974.8 million. The company's, Q1 earnings came out today. </li>
<li>PubMatic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PUBM#NASDAQ">PUBM</a>) stock rose 8.24% to $26.0. The market value of their outstanding shares is at $1.3 billion. The company's, Q1 earnings came out today. </li>
<li>Cineverse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNVS#NASDAQ">CNVS</a>) shares increased by 5.0% to $0.87. The market value of their outstanding shares is at $11.6 million. </li>
<li>iHeartMedia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IHRT#NASDAQ">IHRT</a>) stock rose 4.84% to $2.38. The company's market cap stands at $344.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CuriosityStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURI#NASDAQ">CURI</a>) shares fell 18.7% to $1.0 during Tuesday's after-market session. The market value of their outstanding shares is at $53.3 million. As per the press release, Q1 earnings came out today. </li>
<li>ZoomInfo Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NASDAQ">ZI</a>) shares declined by 16.02% to $13.48. The market value of their outstanding shares is at $5.0 billion. As per the news, the Q1 earnings report came out today. </li>
<li>MediaAlpha (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAX#NYSE">MAX</a>) stock fell 11.19% to $19.7. The market value of their outstanding shares is at $1.0 billion. As per the press release, Q1 earnings came out 4 days ago. </li>
<li>Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) shares fell 10.31% to $8.88. The company's market cap stands at $1.4 billion. </li>
<li>Super League Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLE#NASDAQ">SLE</a>) shares decreased by 9.71% to $1.21. The market value of their outstanding shares is at $7.8 million. </li>
<li>Loop Media (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LPTV#AMEX">LPTV</a>) stock fell 6.53% to $0.23. The company's market cap stands at $16.0 million. As per the news, the Q2 earnings report came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

CNVS

CURI

IHRT

KIND

LPTV

PUBM

RDDT

12 Communication Services Stocks Moving In Tuesday's After-Market Session

Follows Completion of Early Adopter Program with Fortune 500 Customers
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.marchex.com%2F&amp;esheet=53966332&amp;newsitemid=20240430954383&amp;lan=en-US&amp;anchor=Marchex&amp;index=1&amp;md5=84bc133dc1b2ea57e2da398c5e30327c">Marchex</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced that it has launched its Sentiment Suite product offering across multiple application programming interfaces (APIs) following completion of an extensive early adopter program with Fortune 500 companies and other customers.
A key element of Marchex's conversation intelligence platform, Sentiment Suite combines structured and unstructured data to provide a comprehensive view of customer emotion throughout conversations with businesses. For businesses of all sizes, Sentiment Suite's AI-driven insights include:
<ul>
<li>Customer Emotion, which provides a high-level assessment of whether conversations are positive, negative, or neutral.</li>
<li>Emotion Categories, which assigns specific sentiments such as satisfied, frustrated, or confused to callers, enabling tailored customer response strategies.</li>
<li>View of Business, which combines emotion ratings or scoring, and call context to infer whether the customer perceives a business positively, negatively, or neutrally.</li>
</ul>
Today's launch follows an 8-week early adopter program that scored more than 58,000 completed conversations, across more than a dozen diverse organizations. Upon completion of the early adopter period, Marchex conducted comprehensive interviews with the participants. The feedback showed how Sentiment Suite can deliver highly impactful operational value, by combining structured and unstructured data, qualitatively delivered to customers in actionable ways. Specific examples include:
<ul>
<li>A Fortune 500 company reported that Sentiment Suite helped validate its belief that directing all customer calls to a central call center would create better business outcomes than if it delivered the conversations to varied locations. Previously, the company did not have the data to prove this thesis, but its adoption of Marchex Sentiment Suite generated specific data tied to helpful and unhelpful agents, which enabled the company to determine where calls are handled most effectively for greatest customer satisfaction. By utilizing the Sentiment Suite data and intelligence, this company was able to create more effective workflows that drove improved customer satisfaction and operational excellence.</li>
<li>A major healthcare industry association deployed Sentiment Suite and found for its line of business, localized call handling is crucial. Sentiment Suite's specific data and intelligence for the organization showed local communication was in fact most effective in terms of answering calls, following up on leads, and supporting a positive customer experience – all of which are connected to revenue acceleration.</li>
<li>A large home services franchise highlighted deploying Sentiment Suite enabled it to more strategically align marketing spend to focus on specific areas that returned both more leads and satisfied customers. As part of the process, Sentiment Suite identified calls where customers were frustrated or dissatisfied and helped the company determine why customers had these feelings or negative views of the business, as well as which actions to take to improve them.</li>
</ul>
"Understanding the emotional sentiment of our customers as they interact with our business, in real-time, gives us a powerful application," Ryan Field, Vice President of Marketing at Sierra Heating and Cooling, an early adopter participant. "It can help drive strategic marketing insights and operational improvements to help our business."
"We are thrilled to launch Sentiment Suite powered by our AI and conversational intelligence that not only understands the emotions occurring within customer conversations, but it also empowers Fortune 500 companies with the strategic insights needed to help them achieve operational excellence," said Edwin Miller, Marchex CEO. "Sentiment Suite delivers critical and actionable insights that improve customer experience and drive revenue growth."

Marchex Launches Generative AI-Powered Sentiment Suite Across Multiple APIs

<h3>Gainers</h3>
<ul>
<li>Cardlytics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDLX#NASDAQ">CDLX</a>) stock moved upwards by 48.3% to $12.14 during Friday's pre-market session. The company's market cap stands at $476.5 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>HWH International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWH#NASDAQ">HWH</a>) shares rose 8.1% to $1.2. The company's market cap stands at $19.4 million. </li>
<li>TuanChe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TC#NASDAQ">TC</a>) shares moved upwards by 7.78% to $1.8. The company's market cap stands at $2.9 million. </li>
<li>Angi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGI#NASDAQ">ANGI</a>) stock moved upwards by 7.14% to $2.7. The company's market cap stands at $1.3 billion. </li>
<li>Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARAP#NASDAQ">PARAP</a>) shares rose 6.91% to $14.07. </li>
<li>Getty Images Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GETY#NYSE">GETY</a>) stock moved upwards by 6.79% to $5.5. The market value of their outstanding shares is at $2.2 billion. As per the news, the Q4 earnings report came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) shares fell 11.5% to $1.15 during Friday's pre-market session. The market value of their outstanding shares is at $49.8 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Kuke Music Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KUKE#NYSE">KUKE</a>) shares decreased by 9.64% to $2.25. The market value of their outstanding shares is at $74.8 million. </li>
<li>Gaxos.AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GXAI#NASDAQ">GXAI</a>) shares fell 8.38% to $7.88. The market value of their outstanding shares is at $7.7 million. </li>
<li>Cheer Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHR#NASDAQ">CHR</a>) shares fell 7.0% to $2.79. The company's market cap stands at $28.0 million. The company's, FY earnings came out yesterday. </li>
<li>Baosheng Media Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAOS#NASDAQ">BAOS</a>) stock declined by 5.61% to $3.34. The market value of their outstanding shares is at $5.1 million. </li>
<li>Grom Social Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GROM#NASDAQ">GROM</a>) stock decreased by 5.49% to $0.93. The company's market cap stands at $1.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANGI

BAOS

CDLX

GETY

GROM

GXAI

KUKE

PARAP

12 Communication Services Stocks Moving In Friday's Pre-Market Session

Marchex Says Q1 Revenue Is Anticipated To Be Somewhat Lower Than Q4 Levels

Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) reported quarterly sales of $12.395 million which missed the analyst consensus estimate of $12.750 million by 2.78 percent. This is a 0.84 percent increase over sales of $12.292 million the same period last year.

Marchex Q4 Sales $12.395M Miss $12.750M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; Pharming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) is projected to report earnings for its fourth quarter.
&bull; ImmunoPrecise Antibodies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPA#NASDAQ">IPA</a>) is likely to report quarterly loss at $0.07 per share on revenue of $4.50 million.
&bull; G-III Apparel Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIII#NASDAQ">GIII</a>) is projected to report quarterly earnings at $0.67 per share on revenue of $817.48 million.
&bull; Dick&#39;s Sporting Goods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) is estimated to report quarterly earnings at $3.35 per share on revenue of $3.80 billion.
&bull; Protalix BioTherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PLX#AMEX">PLX</a>) is likely to report quarterly loss at $0.03 per share on revenue of $5.80 million.
&bull; Hello Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOMO#NASDAQ">MOMO</a>) is likely to report quarterly earnings at $0.34 per share on revenue of $405.61 million.
&bull; Weibo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WB#NASDAQ">WB</a>) is expected to report quarterly earnings at $0.49 per share on revenue of $455.09 million.
&bull; Futu Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>) is projected to report quarterly earnings at $0.96 per share on revenue of $331.79 million.
&bull; Akebia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKBA#NASDAQ">AKBA</a>) is expected to report quarterly loss at $0.04 per share on revenue of $55.39 million.
&bull; Kandi Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNDI#NASDAQ">KNDI</a>) is projected to report earnings for its fourth quarter.
&bull; Benson Hill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHIL#NYSE">BHIL</a>) is estimated to report quarterly loss at $0.17 per share on revenue of $87.30 million.
&bull; KE Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>) is likely to report quarterly earnings at $0.18 per share on revenue of $2.63 billion.
&bull; Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) is expected to report quarterly earnings at $1.75 per share on revenue of $9.78 billion.
&bull; Hudson Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSON#NASDAQ">HSON</a>) is estimated to report quarterly earnings at $0.20 per share on revenue of $38.02 million.
&bull; InfuSystems Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INFU#AMEX">INFU</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $30.00 million.
&bull; HF Foods Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HFFG#NASDAQ">HFFG</a>) is likely to report earnings for its fourth quarter.
&bull; Burford Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUR#NYSE">BUR</a>) is estimated to report earnings for its Fiscal Year 2023.
&bull; Ucloudlink Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCL#NASDAQ">UCL</a>) is expected to report quarterly earnings at $0.05 per share on revenue of $23.60 million.
&bull; Xunlei (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XNET#NASDAQ">XNET</a>) is likely to report earnings for its fourth quarter.
&bull; Build-A-Bear Workshop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBW#NYSE">BBW</a>) is projected to report quarterly earnings at $1.32 per share on revenue of $150.45 million.
&bull; Global X Guru Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GURU#NYSE">GURU</a>) is projected to report quarterly loss at $0.05 per share on revenue of $6.85 million.
&bull; Century Casinos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTY#NASDAQ">CNTY</a>) is expected to report quarterly loss at $0.36 per share on revenue of $142.31 million.
&bull; Katapult Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPLT#NASDAQ">KPLT</a>) is expected to report quarterly loss at $1.79 per share on revenue of $55.81 million.
&bull; UroGen Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) is estimated to report quarterly loss at $0.68 per share on revenue of $22.57 million.
&bull; Agenus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGEN#NASDAQ">AGEN</a>) is projected to report quarterly loss at $0.05 per share on revenue of $47.05 million.
&bull; RumbleON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) is estimated to report quarterly loss at $0.51 per share on revenue of $339.48 million.
&bull; Alarum Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAR#NASDAQ">ALAR</a>) is expected to report quarterly earnings at $0.25 per share on revenue of $7.00 million.
&bull; Autolus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUTL#NASDAQ">AUTL</a>) is estimated to report quarterly loss at $0.25 per share on revenue of $360 thousand.
&bull; United Homes Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UHG#NASDAQ">UHG</a>) is projected to report earnings for its first quarter.
&bull; BK Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BKTI#AMEX">BKTI</a>) is likely to report earnings for its fourth quarter.
&bull; Solo Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTC#NYSE">DTC</a>) is expected to report quarterly earnings at $0.17 per share on revenue of $166.15 million.
&bull; Mondee Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOND#NASDAQ">MOND</a>) is likely to report quarterly loss at $0.12 per share on revenue of $55.00 million.
&bull; GoHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOCO#NASDAQ">GOCO</a>) is likely to report quarterly earnings at $2.72 per share on revenue of $363.88 million.
&bull; SecureWorks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWX#NASDAQ">SCWX</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $87.18 million.
&bull; Aveanna Healthcare Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAH#NASDAQ">AVAH</a>) is projected to report quarterly loss at $0.02 per share on revenue of $467.40 million.
&bull; PSQ Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSQH#NYSE">PSQH</a>) is expected to report quarterly loss at $0.47 per share on revenue of $2.47 million.
&bull; Canadian Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $1.69 billion.
&bull; CION Invt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CION#NYSE">CION</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $58.33 million.
<h3>Companies Reporting After The Bell</h3>
&bull; Blend Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) is expected to report quarterly loss at $0.09 per share on revenue of $36.93 million.
&bull; Montauk Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTK#NASDAQ">MNTK</a>) is estimated to report quarterly earnings at $0.07 per share on revenue of $56.87 million.
&bull; Getty Images Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GETY#NYSE">GETY</a>) is estimated to report quarterly earnings at $0.01 per share on revenue of $216.46 million.
&bull; Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) is likely to report quarterly earnings at $7.53 per share on revenue of $3.53 billion.
&bull; Skillz (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKLZ#NYSE">SKLZ</a>) is projected to report quarterly loss at $1.41 per share on revenue of $38.09 million.
&bull; Rigetti Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) is expected to report quarterly loss at $0.13 per share on revenue of $3.22 million.
&bull; Smartsheet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMAR#NYSE">SMAR</a>) is estimated to report quarterly earnings at $0.18 per share on revenue of $255.38 million.
&bull; Phreesia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHR#NYSE">PHR</a>) is expected to report quarterly loss at $0.26 per share on revenue of $93.53 million.
&bull; Despegar.com (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DESP#NYSE">DESP</a>) is projected to report quarterly earnings at $0.17 per share on revenue of $191.43 million.
&bull; Frequency Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEIM#NASDAQ">FEIM</a>) is projected to report earnings for its third quarter.
&bull; Pyxis Tankers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXS#NASDAQ">PXS</a>) is projected to report earnings for its fourth quarter.
&bull; American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) is likely to report quarterly earnings at $0.27 per share on revenue of $172.90 million.
&bull; The One Group Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKS#NASDAQ">STKS</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $98.04 million.
&bull; Urgently (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULY#NASDAQ">ULY</a>) is likely to report earnings for its fourth quarter.
&bull; Vaxart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VXRT#NASDAQ">VXRT</a>) is likely to report quarterly loss at $0.14 per share on revenue of $1.25 million.
&bull; Evoke Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) is likely to report quarterly loss at $0.50 per share on revenue of $1.63 million.
&bull; Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $12.75 million.
&bull; Kopin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>) is projected to report quarterly loss at $0.02 per share on revenue of $9.03 million.
&bull; Eastman Kodak (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KODK#NYSE">KODK</a>) is projected to report earnings for its fourth quarter.
&bull; Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) is projected to report quarterly earnings at $0.26 per share on revenue of $275.87 million.
&bull; Tilly&#39;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) is projected to report quarterly loss at $0.22 per share on revenue of $171.65 million.
&bull; CytoSorbents (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSO#NASDAQ">CTSO</a>) is projected to report quarterly loss at $0.14 per share on revenue of $9.28 million.
&bull; Energy Transfer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>) is projected to report quarterly earnings at $0.22 per share on revenue of $125.84 million.
&bull; Allogene Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLO#NASDAQ">ALLO</a>) is projected to report quarterly loss at $0.45 per share on revenue of $20 thousand.
&bull; Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) is expected to report earnings for its fourth quarter.
&bull; Redwire (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) is expected to report quarterly loss at $0.12 per share on revenue of $59.72 million.
&bull; Fathom Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTHM#NASDAQ">FTHM</a>) is estimated to report quarterly loss at $0.32 per share on revenue of $80.97 million.
&bull; Brilliant Earth Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRLT#NASDAQ">BRLT</a>) is estimated to report quarterly earnings at $0.01 per share on revenue of $124.61 million.
&bull; Karat Packaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRT#NASDAQ">KRT</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $95.48 million.
&bull; Mobile Infrastructure (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BEEP#AMEX">BEEP</a>) is estimated to report earnings for its fourth quarter.
&bull; Babcock &amp; Wilcox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BW#NYSE">BW</a>) is likely to report quarterly loss at $0.03 per share on revenue of $256.27 million.
&bull; Cardlytics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDLX#NASDAQ">CDLX</a>) is projected to report quarterly earnings at $0.12 per share on revenue of $89.55 million.
&bull; Eton Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETON#NASDAQ">ETON</a>) is expected to report quarterly loss at $0.04 per share on revenue of $7.70 million.
&bull; EverCommerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVCM#NASDAQ">EVCM</a>) is expected to report quarterly earnings at $0.13 per share on revenue of $172.41 million.
&bull; Co-Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODX#NASDAQ">CODX</a>) is expected to report quarterly loss at $0.20 per share on revenue of $3.62 million.
&bull; Acacia Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) is likely to report quarterly earnings at $0.07 per share on revenue of $8.00 million.
&bull; Alta Equipment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTG#NYSE">ALTG</a>) is estimated to report quarterly loss at $0.05 per share on revenue of $483.69 million.
&bull; Wheaton Precious Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPM#NYSE">WPM</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $291.55 million.
&bull; Spruce Power Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPRU#NYSE">SPRU</a>) is likely to report earnings for its fourth quarter.
&bull; aTyr Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIFE#NASDAQ">LIFE</a>) is estimated to report quarterly loss at $0.24 per share on revenue of $50 thousand.
&bull; Clipper Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLPR#NYSE">CLPR</a>) is projected to report earnings for its fourth quarter.
&bull; Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) is likely to report quarterly earnings at $4.38 per share on revenue of $5.14 billion.
&bull; Heritage Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HGBL#NASDAQ">HGBL</a>) is expected to report quarterly earnings at $0.07 per share on revenue of $15.35 million.
&bull; NuScale Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) is projected to report quarterly loss at $0.14 per share on revenue of $8.94 million.
&bull; Altus Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPS#NYSE">AMPS</a>) is expected to report quarterly loss at $0.01 per share on revenue of $43.93 million.
&bull; Molecular Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOLN#NASDAQ">MOLN</a>) is likely to report earnings for its Fiscal Year 2023.
&bull; FutureFuel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FF#NYSE">FF</a>) is likely to report earnings for its fourth quarter.
&bull; Harte-Hanks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HHS#NASDAQ">HHS</a>) is expected to report quarterly earnings at $0.12 per share on revenue of $47.00 million.
&bull; Blink Charging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) is likely to report quarterly loss at $0.31 per share on revenue of $35.64 million.
&bull; PagerDuty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PD#NYSE">PD</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $110.40 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ACTG

AGEN

AGRO

AKBA

ALAR

ALLO

ALTG

AMPS

AUTL

AVAH

Mobile Infrastructure Corporation Common Stock

BEEP

BEKE

BHIL

BKTI

BLND

BLNK

BRLT

CION

CLPR

CNTY

CODX

CSIQ

CTSO

DESP

ETON

EVCM

EVOK

FEIM

FUTU

GIII

GOCO

GURU

HFFG

HGBL

HSON

INFU

KNDI

KODK

KOPN

KPLT

LIFE

MNTK

MOLN

MOMO

MOND

PHAR

PSQH

RGTI

RMBL

SCWX

SKLZ

SMAR

Spruce Power Holding Corporation Class A Common Stock

SPRU

STKS

TLYS

ULTA

URGN

VXRT

XNET

ZUMZ

Earnings Scheduled For March 14, 2024

Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) is set to give its latest quarterly earnings report on Thursday, 2024-03-14. Here's what investors need to know before the announcement.
Analysts estimate that Marchex will report an earnings per share (EPS) of $0.00. 
Marchex bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.02, which was followed by a 4.48% increase in the share price the next day.
Here's a look at Marchex's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.03</td>
<td>-0.07</td>
<td>-0.05</td>
<td>-0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.01</td>
<td>-0.03</td>
<td>-0.08</td>
<td>-0.05</td>
</tr>
<tr>
<td>Price Change %</td>
<td>4.0%</td>
<td>-7.000000000000001%</td>
<td>-3.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1710352927_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Marchex were trading at $1.3 as of March 12. Over the last 52-week period, shares are down 28.44%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/MCHX/earnings">To track all earnings releases for Marchex visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Preview Of Marchex's Earnings

The Dow Jones closed higher by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Marchex </h3>
<ul>
<li>The Trade: Marchex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mchx#NASDAQ">MCHX</a>) 10% owner Jonathan Brolin <a href="https://www.benzinga.com/quote/MCHX/analyst-ratings"> acquired a total of 26,975 shares </a> an average price of $1.40. To acquire these shares, it cost around $37,714.</li>
<li>What&rsquo;s Happening: Marchex posted a narrower-than-expected quarterly loss.</li>
<li>What Marchex Does: Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business.</li>
</ul>
<h3>Lexicon Pharmaceuticals</h3>
<ul>
<li>The Trade: Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) CEO Lonnel Coats <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 10,000 shares </a> at an average price of $1.01. To acquire these shares, it cost around $10,100.</li>
<li>What&rsquo;s Happening: Lexicon Pharmaceuticals posted in-line loss for its third quarter.</li>
<li>What Lexicon Pharmaceuticals Does: Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/23/11/35742179/how-to-earn-500-a-month-from-wynn-resorts-stock-following-earnings-beat"> How To Earn $500 A Month From Wynn Resorts Stock Following Earnings Beat </a>
<h3>Blend Labs </h3>
<ul>
<li>The Trade: Blend Labs, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/blnd#NYSE">BLND</a>) Head of Finance and Admin. Amir Jafari <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 12,610 shares </a> at an average price of $1.22. The insider spent around $15,350 to buy those shares.</li>
<li>What&rsquo;s Happening: Blend Labs posted upbeat third-quarter sales.</li>
<li>What Blend Labs Does: Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers.</li>
</ul>
<h3>ESS Tech </h3>
<ul>
<li>The Trade: ESS Tech, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gwh#NYSE">GWH</a>) Director Harry Quarls <a href="https://www.benzinga.com/quote/LTRPA/analyst-ratings"> acquired a total of 46,814 shares </a> at an average price of $1.10. The insider spent around $51,631 to buy those shares. The company&rsquo;s Director Teamey Kyle also bought 1,000 shares.</li>
<li>What&rsquo;s Happening: ESS Tech posted a narrower-than-expected loss for the third quarter.</li>
<li>What ESS Tech Does: ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology.</li>
</ul>
&nbsp;
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

LXRX

Insiders Buying Blend Labs And 3 Other Stocks Under $2

Marchex Q4 Revenue Anticipated To Be At Or Near Q3 Levels

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Marchex (NASDAQ:<a href="https://investorplace.com/stock-quotes/mchx-stock-quote/">MCHX</a>) just reported results for the second quarter of 2024.<ul><li>Marchex reported earnings per share of -1 cent. This met the analyst estimate for EPS of -1 cent.</li><li>The company reported revenue of $12.07 million.</li><li>This was 0.54% worse than the analyst estimate for revenue of $12.14 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/mchx-stock-earnings-marchex-for-q2-of-2024/">MCHX Stock Earnings: Marchex Meets EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

MCHX Stock Earnings: Marchex Meets EPS, Misses Revenue for Q2 2024

Marchex Non-GAAP EPS of -$0.01, revenue of $12.1M

Roth MKM analyst Darren Aftahi maintained a Buy rating on Marchex (MCHX – Research Report) today and set a price target of $2.50. Darren Aftahi has...

Buy Rating Affirmed for Marchex on OneStack-Driven Growth and Margin Expansion

Marchex, Inc. (MCHX) Q2 2024 Earnings Call Transcript

Analyst Darren Aftahi from Roth MKM maintained a Buy rating on Marchex (MCHX – Research Report) and keeping the price target at $2.50. Darren Aftah...

Marchex's OneStack Initiative: A Path to Enhanced Growth and Investor Attraction

Marchex GAAP EPS of -$0.02 misses by $0.01, revenue of $12.6M in-line

Marchex, Inc. (MCHX) Q3 2024 Earnings Call Transcript

Marchex ( ($MCHX) ) has released its Q3 earnings. Here is a breakdown of the information Marchex presented to its investors. Marchex, Inc. operates...

Marchex Reports Q3 Earnings and Strategic Advances

In a report released on October 31, Michael Latimore from Northland Securities maintained a Buy rating on Marchex (MCHX – Research Report), with a ...

Northland Securities Keeps Their Buy Rating on Marchex (MCHX)

Marchex ( ($MCHX) ) has shared an announcement. Following the re-election of directors at Marchex, Inc.'s 2024 annual stockholder meeting, the comp...

Marchex Approves Stock Options for Directors

Press Releases

Marchex Announces First Quarter Results

Marchex Signs Major International Luxury Automotive Brand to AI-Powered Conversation Intelligence Platform

Marchex wins 2024 APPEALIE SaaS Customer Success Award

Marchex Receives AI Breakthrough Award for "Best Text Generative AI Solution" for its Call Summaries and Sentiment Suite

Marchex to Report Second Quarter 2024 Results on Thursday, August 8, 2024

Marchex Announces Second Quarter 2024 Results

Marchex Partners with DealerOn for Marchex's AI-Powered Conversation Intelligence Solutions

Comments

Marchex

ニュース

最新ニュース Marchex (NASDAQ:MCHX) 株価情報

水曜日, 8 07, 2024

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル